Overview

Transforming challenges into success stories for companies worldwide.

Our approach is anchored in advanced technology, enriched by cultural insights and guided by three core principles - Seamless Integration, Convenient Management and Dynamic Course-correction. By embracing these values, we ensure that every project is executed with meticulous care, precision and forward-thinking.

Our Expertise

Precision-driven solutions for modern pharmaceuticals

Biotechnology

At Pharma Access, we bring over 24 years of expertise in biotechnology manufacturing, delivering turnkey projects that meet stringent industry regulations. We design advanced facilities for biologics, vaccines, and therapies, ensuring excellence and compliance from bioprocessing to fill-finish.

We specialize in:

  • Customized facilities
  • GMP-compliant technologies
  • Advanced fill-finish capabilities
  • Environmental monitoring
  • Validation and documentation
  • Well-trained personnel

Products

  • mAbs, Antibody Drug Conjugates (ADC)
  • Cell and Gene Therapy (CGT)
  • Immunotherapy (Plasma Fractionation)
  • Vaccines
  • Peptides
  • Hormones (Insulin)

Sterile Manufacturing

In sterile manufacturing, key aspects such as aseptic processing, terminal sterilization, and clean utilities are essential for ensuring product safety and compliance with cGMP standards. At Pharma Access, we help clients set up advanced sterile manufacturing facilities that prioritize these elements.

We focus on several key aspects to guarantee product integrity and compliance, including:

  • State-of-the-art facility design for optimal sterile conditions.
  • Comprehensive area classification to minimize contamination risks.
  • Rigorous validation methods for all critical manufacturing steps.
  • Proficiency in aseptic techniques for filling and sealing.
  • Strict monitoring of environmental controls.
  • Continuous training for personnel in sterile practices.
  • End-to-end solutions for a variety of sterile products.
  • Commitment to regulatory compliance with global standards.
  • Effective risk management through audits and data tracking.

With a focus on quality and customer satisfaction, we at Pharma Access are dedicated to providing effective sterile manufacturing solutions that meet the needs of the pharmaceutical industry.

Products

  • Nasal Drops
    • SVP – Vials, Pre-filled Syringes, Cartridges, Ampoules
    • LVP
  • Non-Injectables
    • Topical – Solutions, Sprays, Gels, Ointments
    • Ophthalmic – Solutions, Gels, Ointments
    • Nasal
    • Inhalations
    • Otic
    • Implants
  • Lyophilized Products

Oral Solid Dosage

Your trusted partner for seamless Oral Solid Dosage (OSD) manufacturing. Specializing in tablets and capsules, we bring over 24 years of expertise in designing and executing flexible, compliant, and cost-effective facilities.

We excel in helping our customers seamlessly achieve and maintain Oral Solid Dosage (OSD) manufacturing. Our extensive range of services ensures the execution of manufacturing facilities that are:

  • Flexible with agile
  • Complaint with all regulatory bodies
  • Facilitates cost-effective manufacturing for faster ROI

Our team brings unparalleled expertise and field knowledge in executing turnkey facilities for finished formulations. We help clients navigate the challenges of increasing demands, evolving technologies, and intense competition in the OSD product market. By leveraging our extensive experience, we optimize productivity through comprehensive engineering and execution services, including:

  • Agile multiproduct facility design
  • Optimization of material & personnel flows
  • Optimization of logistics
  • Technology transfer

Products

  • Tablets
  • Capsules
  • Caplets
  • Sachets
  • Lozenges
  • Chewable Tablets
  • Effervescent Tablets
  • Sublingual Tablets
  • Buccal Tablets
  • Orally Disintegrating Tablets
  • Delayed-Release Tablets
  • Extended-Release Tablets

Oral Liquid Dosage

Yet another segment in which Pharma Access specializes in providing turnkey solutions. Supplying processing plants for liquids like ophthalmic drops, nasal drops, liquid orals, ointment and creams. The spectrum of services offered in this category includes supply, installation and commissioning of the following:

  • Liquids and ointment manufacturing plants
  • Liquids and ointment filling lines
  • Packaging lines
  • CIP & SIP system for cleaning and sanitization of systems

Apart from providing flexible and cost-effective systems, a key priority for us is to ensure that the equipment we supply also meet the regulatory requirements. Documentation requirement at every stage is captured right into our project delivery methodology at various stages like design, engineering, procurement, installation & validation. Offering tailor-made solutions is our tradition while providing:

  • Equipment and piping layout for liquids and ointment systems
  • Transfer piping systems
  • Automation system as per 21 CFR Part 11
  • System qualification documents like DQ, FAT, IQ, OQ protocols
  • Efficient site execution teams for erection and assistance in the validation process cycles
  • Swift after sales service

Products

  • Syrups
  • Solutions
  • Suspensions
  • Emulsions
  • Tinctures
  • Oral Drops
  • Others

bangalore aragen biologics

Production Capacity (per annum)

  • 15 million doses of mAbs
  • Drug substance manufacturing facility
  • 2x2KL single-use bioreactors
  • 14,000 m2

    Built-up area

  • 23,000 m2

    Ducting

  • 8,500 m2

    MCR

  • 60,000 mtrs

    Cables

Aragen Biologics Banglore Background
Visual representation of a confidential project in the UAE, key aspects of the project's design and infrastructure.

Confidential UAE

Production Capacity (per annum)

  • 30 million doses of mAbs
  • 2 suits for 2x2KL single-use bioreactors
  • 26,000 m2

    Built-up area

  • 33,500 m2

    Ducting

  • 28,000 m2

    MCR

  • 1,50,000 mtrs

    Cables

Pharma Access project image from UAE, highlighting advanced healthcare and pharmaceutical facility solutions.

Algeria Inphamedis

Production Capacity (per annum)

  • LVP: 12 million units
  • Opthalmic: 6 million units
  • Ampoule / Vial: 10 million units
  • 12,000 m2

    Built-up area

  • 18,000 m2

    Ducting

  • 11,500 m2

    MCR

  • 70,000 mtrs

    Cables

PharmaAccess project image of Inphamedis, Algeria background

Saudi Arabia SPPF

Production Capacity (per annum)

  • Sterile: 3 million units of 100 ml Fill volume
  • OLD: 2 million units of 500 ml Fill volume
  • OSD: 60 million doses
  • 10,000 m2

    Built-up area

  • 10,000 m2

    Ducting

  • 8,500 m2

    MCR

  • 40,000 mtrs

    Cables

Saudi Veterinary Pharmacy Products Factory

Algeria Sophal

Production Capacity (per annum)

  • Dry Injection (Cephalosporin): 13 million units
  • 3,500 m2

    Built-up area

  • 4,500 m2

    Ducting

  • 2,500 m2

    MCR

  • NA

    Cables

project image of Sophal, Algeria, highlighting advanced pharmaceutical and healthcare facility solutions.

Algeria Biothera

Production Capacity (per annum)

  • Ophthalmic: 3 million
  • PFS: 4 Millon
  • Amp Vial: 15 million
  • 6,200 m2

    Built-up area

  • 12,000 m2

    Ducting

  • 5,200 m2

    MCR

  • 47,000 mtrs

    Cables

Biothera, Algeria, showcasing modern solutions for pharmaceutical and healthcare facilities.

Kuwait Al Shifa

Production Capacity (per annum)

  • Vials: 8 million unit
  • Ampoule: 18 million unit
  • Ophthalmic: 62 million unit
  • 22,000 m2

    Built-up area

  • 21,000 m2

    Ducting

  • 12,000 m2

    MCR

  • 72,500 mtrs

    Cables

Al Shifa, Kuwait, highlighting innovative solutions for healthcare and pharmaceutical facilities.

Oman Izz Pharma, Nizwa

Production Capacity (per annum)

  • Sterile: 30 million doses
  • 20,000 m2

    Built-up area

  • 7,600 m2

    Ducting

  • 5,500 m2

    MCR

  • 60,000 mtrs

    Cables

Izz Pharma, Nizwa, showcasing advanced solutions for pharmaceutical manufacturing and facilities.

Oman Menagen

Production Capacity (per annum)

  • OSD: 65 million units
  • 8,500 m2

    Built-up area

  • 8,000 m2

    Ducting

  • 5,500 m2

    MCR

  • 35,000 mtrs

    Cables

Menagen, Oman, highlighting cutting-edge solutions for pharmaceutical and healthcare facilities.

Jordan Pharmatek

Production Capacity (per annum)

  • OSD Tablets: 150 million units | Capsules: 60 million units
  • OLD: 8 million units | Sachet: 30 million units
  • 9,000 m2

    Built-up area

  • 16,000 m2

    Ducting

  • 10,000 m2

    MCR

  • 84,000 mtrs

    Cables

Pharmatek, Jordan, showcasing innovative solutions for pharmaceutical manufacturing and healthcare facilities.

Algeria Merinal Laboratories

Production Capacity (per annum)

  • OSD: Tables - 70 million | Hard Capsules - 28 million
  • OLD: 77 million
  • Ointment: 64 million
  • Softgel Capsule: 35 million
  • 15,000 m2

    Built-up area

  • 35,000 m2

    Ducting

  • 23,000 m2

    MCR

  • 2,70,000 mtrs

    Cables

Merinal Laboratories, Algeria, highlighting advanced solutions for pharmaceutical manufacturing and facilities.

Algeria Saidal, Onco Pharm

Production Capacity (per annum)

  • OSD: Tablet / Capsule – 24 million units
  • Vials: 9 million units
  • 14,000 m2

    Built-up area

  • 33,000 m2

    Ducting

  • 15,000 m2

    MCR

  • 200,000 mtrs

    Cables

Onco Pharm Saidal, showcasing state-of-the-art solutions for pharmaceutical production and healthcare facilities.

Algeria Alfacare SARL

Production Capacity (per annum)

  • Oncological OSD Line: 30 million doses
  • Oncological Injectable Line (Vial and Lyophilized Vials): 6 million units
  • 9,800 m2

    Built-up area

  • 10,000 m2

    Ducting

  • 7,200 m2

    MCR

  • 96,500 mtrs

    Cables

Alfacare Sarl, Algeria, highlighting advanced pharmaceutical and healthcare facility solutions.

Algeria Onyx Pharmaceutique

Production Capacity (per annum)

  • OSD Tablets: 280 million units | Capsules: 60 million units
  • Ointment: 3 million units
  • 6,500 m2

    Built-up area

  • 12,000 m2

    Ducting

  • 6,200 m2

    MCR

  • 60,500 mtrs

    Cables

Onyx Pharmaceutique, Algeria, showcasing innovative solutions for pharmaceutical manufacturing and facilities.

Algeria Janismed

Production Capacity (per annum)

  • OSD Tablets: 170 million units | Capsules: 20 million units
  • OLD: 20 million units
  • 6,200 m2

    Built-up area

  • 12,000 m2

    Ducting

  • 5,200 m2

    MCR

  • 50,500 mtrs

    Cables

Janismed Algeria
Top